Results 171 to 180 of about 4,466,597 (305)
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia+17 more
wiley +1 more source
Brewer's spent grain: Unveiling innovative applications in the food and packaging industry. [PDF]
Aradwad P+4 more
europepmc +1 more source
EFFECTS OF FEEDING WITH CALCIUM SALTS ON THE CALCIUM CONTENT OF THE BLOOD
W. Denis, A. S. Minot
openalex +1 more source
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley +1 more source
A practical framework for developing a virtual reality-based anatomy education application: key content and technical requirements. [PDF]
Esmaeeli E+5 more
europepmc +1 more source
Clinical significance of stratifying prostate cancer patients through specific circulating genes
We tested a specific panel of genes representative of luminal, neuroendocrine and stem‐like cells in the blood of prostate cancer patients, showing predictive value from diagnosis to late stages of disease. This approach allows monitoring of treatment responses and outcomes at specific time points in trajectories.
Seta Derderian+12 more
wiley +1 more source
Study on the resistivity characteristics and mechanism of silt clay under different initial conditions. [PDF]
Wang C, Bao F, Lu Y.
europepmc +1 more source